Abstract
Lytic and blastic lesions have been associated to malignant tumours, such as solid cancer (breast cancer, renal cancer, prostate cancer, malignant melanoma or thyroid tumours). Although a mixed pattern with lytic and blastic lesions is due to metastatic tumour, this is not the only possible origin. The following case shows a systematic. This case report shows the number of tests that were made in order to discover the origin of osteolytic and osteoblastic lesions and it is notable that there is not an occult neoplasia on every occasion.
Similar content being viewed by others
References
Abbruzzese JL, Abbruzzese MC, Hess HR et al (1994) Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 12:1272–1281
Rougraff BT, Kneisl JS, Simon MA (1993) Skeletal metastases of unknown origin: a prospective study of a diagnostic strategy. J Bone Joint Surg 75:1276–1281
Du Y, Cullum I, Illidge TM et al (2007) Fusion of metabolic function and morphology: sequential (18F) Fluorodeoxyglucose Positron-Emission Tomography/Computed tomography studies yield new insights into the natural history of bone metastases in breast cancer. J Clin Oncol 25:3440–3447
Gamradt SC, Feeley BT, Lui NQ et al (2005) The effect of cyclooxygenase-2 (COX-2) inhibition on human prostate cancer induced osteoblastic and osteolytic lesions in bone. Anticancer Res 25:107–115
Omi R, Hatori M, Sano H et al (2004) Super Bone Scan due to bone marrow metastases appearing 19 years alter surgery for early gastric cancer — a case report. Upsala J Med Sci 109:49–56
Dispenzieri A, Kyle R, Lacy M et al (2003) POEMS syndrome: definitions and long-term outcome. Blood 101:2496–2506
Wang JC, Kim DA, Goldberg M (1996) Anaplastic large cell Ki-1 lymphoma: primary bone presentation in an elderly man. Acta Haematol 96:45–49
Packer CD, Mileti LM (2005) Vertebral sarcoidosis mimicking lytic osseous metastases: development 16 years after apparent resolution of thoracic sarcoidosis. J Clin Rheumatol 11:105–108
Simiel Narvarte A, Novoa Sanjurjo F, Gómez Rodríguez N et al (2004) Enfermedad de Erdheim-Chester e histiocitosis de células de Langerhans. ?Una asociación fortuita? An Med Interna 21:593–596
Abdelwahab IF, Klein MJ, Springfield DS et al (2004) A solitary lesion of talus with mixed sclerotic and lytic changes: Rosai-Dorfman disease of 25 years’ duration. Skeletal Radiol 33:230–233
Zanglis A, Andreopoulos D, Zissimopoulos A et al (2005) Positive Tc-99m-MIBI scan in a patient with confirmed Paget’s disease of bone. Clin Nucl Med 30:363–364
Wenstrup RJ, Roca-Espiau M, Weinreb NJ et al (2002) Skeletal aspects of Gaucher disease: a review. Br J Radiol 75[Suppl 1]:A2–A12
Valent R, Horny HP, Escribano L et al (2001) Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 25:603–625
Avila NA, Ling A, Metcalfe DD et al (1998) Mastocytosis: magnetic resonance imaging patterns of marrow disease. Skeletal Radiol 27:119–126
Valent P, Akin C, Sperr WR et al (2003) Diagnosis and treatment of systemic mastocytosis: state of the art. Br J Haematol 122:1–23
Worobec AS (2000) Treatment of systemic mast cell disorders. Hematol Oncol North Am 14:659–687
Hauswirth AW, Simonitsch-Klupp I, Uffmann M et al (2004) Response to therapy with interferonalpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature. Leuk Res 28:249–257
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Molina-Garrido, M.J., Mora, A., Andrada, E. et al. Multiple bone lesions resembling a metastatic origin. An unexpected diagnosis. Clin Transl Oncol 10, 241–245 (2008). https://doi.org/10.1007/s12094-008-0190-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-008-0190-0